Anti-rsv Protein F Nanobody Alx-0171 Uses, Dosage, Side Effects and more
Anti-rsv Protein F Nanobody Alx-0171 is under investigation in clinical trial NCT03468829 (Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection).
| Attribute | Details |
|---|---|
| Trade Name | Anti-rsv Protein F Nanobody Alx-0171 |
| Generic | Gontivimab |
| Gontivimab Other Names | Anti-rsv protein f nanobody alx-0171, Gontivimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
